- 1. AG013736
- [An orally bioavailable tyrosine kinase inhibitor. AG-013736 inhibits the proangiogenic cytokines vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor (PDGF), thereby exerting an anti-angiogenic effect. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=352181&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=352181&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C38718" NCI Thesaurus) ( PDQ )] (UMLS (NCI) C1328149) AG-013736 =Organic Chemical; Pharmacologic Substance
| |